Galactomannan testing during mold-active prophylaxis
- PMID: 25165089
- PMCID: PMC4243699
- DOI: 10.1093/cid/ciu677
Galactomannan testing during mold-active prophylaxis
Keywords: bronchoalveolar lavage; galactomannan; leukemia; prophylaxis.
Comment on
-
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.Clin Infect Dis. 2014 Dec 15;59(12):1696-702. doi: 10.1093/cid/ciu673. Epub 2014 Aug 27. Clin Infect Dis. 2014. PMID: 25165088
Similar articles
-
Serum galactomannan diagnosis of breakthrough invasive fungal disease.Clin Infect Dis. 2015 Apr 15;60(8):1284. doi: 10.1093/cid/civ035. Epub 2015 Jan 26. Clin Infect Dis. 2015. PMID: 25628384 No abstract available.
-
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.Clin Infect Dis. 2014 Dec 15;59(12):1696-702. doi: 10.1093/cid/ciu673. Epub 2014 Aug 27. Clin Infect Dis. 2014. PMID: 25165088
-
Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.Med Mycol. 2017 Jul 1;55(5):528-534. doi: 10.1093/mmy/myw102. Med Mycol. 2017. PMID: 27744310
-
Galactomannan antigenemia as a biomarker for therapeutic response of invasive aspergillosis: implications for clinical trial design and patient care.Expert Rev Mol Diagn. 2018 Jul;18(7):601-604. doi: 10.1080/14737159.2018.1488589. Epub 2018 Jun 20. Expert Rev Mol Diagn. 2018. PMID: 29897826 Review.
-
[Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].Rev Iberoam Micol. 2003 Sep;20(3):103-10. Rev Iberoam Micol. 2003. PMID: 15456366 Review. Spanish.
Cited by
-
Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study.Bone Marrow Transplant. 2017 Feb;52(2):326-329. doi: 10.1038/bmt.2016.279. Epub 2016 Oct 31. Bone Marrow Transplant. 2017. PMID: 27797367 No abstract available.
-
Cost-Effectiveness of Serum Galactomannan Surveillance during Mould-Active Antifungal Prophylaxis.J Fungi (Basel). 2021 May 26;7(6):417. doi: 10.3390/jof7060417. J Fungi (Basel). 2021. PMID: 34073588 Free PMC article.
-
Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience.J Med Microbiol. 2022 Jul;71(7):jmm.0.001564. doi: 10.1099/jmm.0.001564. J Med Microbiol. 2022. PMID: 35819894 Free PMC article.
-
Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies.J Clin Microbiol. 2016 Mar;54(3):771-4. doi: 10.1128/JCM.02969-15. Epub 2015 Dec 23. J Clin Microbiol. 2016. PMID: 26699701 Free PMC article.
References
-
- Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999;340:764–71. - PubMed
-
- Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351:1391–402. - PubMed
-
- Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346:225–34. - PubMed
-
- Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356:348–59. - PubMed
-
- Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med. 2007;356:335–47. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical